Prognostic Value of Inflammatory Mediators in 1-Year Outcome of Acute Ischemic Stroke with Middle Cerebral Artery Stenosis

Table 1

Baseline characteristics of participants.

Demographics and characteristics	Overall (𝑛=977)
Age, years^#	59.97 ± 11.28
Male	716 (73.29)
Duration between symptom onset and blood tests^&, day	3 (1–5)
Duration between symptom onset and MRI procedure^&, day	6 (4, 8)
Previous mRS score
0	790 (80.86)
1	143 (14.64)
2	44 (4.5)
History of, yes (𝑛, %)
Previous cerebral ischemia, TIA, ICH, or SAH	266 (27.23)
Hypertension	788 (80.66)
Diabetes mellitus	409 (41.86)
Hyperlipidemia	802 (82.09)
Current smoking	484 (49.54)
Heavy-to-severe drinking	220 (22.52)
Ischemic heart disease	103 (10.54)
NIHSS score on admission^&	4 (1, 8)
NIHSS score at discharge^&	2 (0, 5)
MCA stenoocclusion
None or <50%	615 (62.95)
50–69%	111 (11.36)
70%–99%	69 (7.06)
100%	182 (18.63)
Peripheral level of inflammatory mediators
WBC^#, ×10^9/L	6.91 ± 1.96
HCY^#, μmol/L	17.74 ± 7.37
hs-CRP^&, mg/L	2.60 (0.90–8.20)
Other laboratory findings on admission
Hgb^#, g/L	142.01 ± 17.54
PLT^#, ×10^9/L	213.03 ± 56.11
FBG^#, mmol/L	5.95 ± 2.21
Cr^#, μmol/L	78.50 ± 29.49
INR^#	0.98 ± 0.14
HDL^#, mmol/L	1.12 ± 0.27
LDL^#, mmol/L	2.76 ± 0.84

^#Continuous variables with normal distribution expressed as mean ± standard deviation.
^&Continuous variables with nonnormal distribution expressed as interquartile range (IQR).
Other values were expressed as 𝑛 (%).
SAH: subarachnoid hemorrhage; ICH: intracerebral hemorrhage; NIHSS: National Institute of Health Stroke Scale; WBC: white blood cell; Hgb: hemoglobin; PLT: platelet; FBG: free blood glycemia; Cr: creatinine; INR: international normalized ratio; HCY: homocysteine; hs-CRP: high sensitivity C-reactive protein; HDL: high-density lipoprotein; and LDL: low-density lipoprotein.